bpc 157 and mots c MOTS-c – True Lab Peptides Peptides in Longevity Medicine: BPC-157,

Laboratories may choose bacteriostatic water when: Working with multi-dose peptide vials requiring repeated access over days or weeks Conducting extended research protocols where peptides must remain stable in solution Minimizing contamination risk is a priority for experimental validity The peptide application tolerates benzyl alcohol (not for highly sensitive cell culture) Cost-effectiveness through reduced waste is important Laboratories may choose sterile water when: The entire reconstituted peptide solution will be used immediately in a single session Performing cell culture experiments where benzyl alcohol cytotoxicity is a concern Working with sensitive assays where preservatives could interfere with results Maximum purity without any additives is required for the protocol Fresh daily reconstitution aligns with existing laboratory workflows Quality Control Considerations Researchers should source reconstitution solutions exclusively from reputable suppliers with established quality control procedures

Batch-specific documentation and Certificates of Analysis provide transparency regarding testing procedures and product specifications

The agency's recommendations on bulk drug substances do not exist in isolation, nor do they answer every question about how these products fit within the broader requirements of the FD&C Act

13 December 2020